Form 4: Biote Corp Director Marc Beer Receives Stock Option Grant

Director Marc D. Beer was granted 195,000 stock options in Biote Corp. with an exercise price of $2.20.

Summary

• Director Marc D. Beer received a grant of 195,000 stock options for Class A Common Stock.
• The options have an exercise price of $2.20 per share.
• The grant date for the options is May 12, 2026.
• The options are set to expire on May 11, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation that does not signal a change in company fundamentals.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• Potential for future shareholder dilution upon the exercise of these options.

Risks

• The value of the options is dependent on the future market performance of Biote Corp. Class A Common Stock.

Future Outlook

The options vest on the earlier of May 12, 2027, or the day prior to the 2027 Annual Meeting of Stockholders, contingent on continuous service.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices intended to incentivize long-term oversight and strategic alignment within the biotechnology and healthcare services sector.

Comparison to Industry Standards

• The use of time-based vesting for director equity is consistent with standard corporate governance practices for publicly traded companies.
• The 10-year expiration term is a standard duration for executive and director stock option plans.

Stakeholder Impact

• Shareholders may experience minor dilution if these options are exercised in the future.

Next Steps

• Vesting of options on May 12, 2027, or the day prior to the 2027 Annual Meeting of Stockholders.

Key Dates

Keywords

Biote Corp, BTMD, Form 4, Director Compensation, Stock Options, Insider Transaction